Cargando…
Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
BACKGROUND: New biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as for detection of disease recurrence. We previously demonstrated the upregulation of leucine-...
Autores principales: | Andersen, John D, Boylan, Kristin LM, Jemmerson, Ronald, Geller, Melissa A, Misemer, Benjamin, Harrington, Katherine M, Weivoda, Starchild, Witthuhn, Bruce A, Argenta, Peter, Vogel, Rachel Isaksson, Skubitz, Amy PN |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949730/ https://www.ncbi.nlm.nih.gov/pubmed/20831812 http://dx.doi.org/10.1186/1757-2215-3-21 |
Ejemplares similares
-
ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand
por: Weivoda, Starchild, et al.
Publicado: (2008) -
Paradoxical Roles of Leucine-Rich α(2)-Glycoprotein-1 in Cell Death and Survival Modulated by Transforming Growth Factor-Beta 1 and Cytochrome c
por: Jemmerson, Ronald
Publicado: (2021) -
Leucine-rich α2-glycoprotein-1 upregulation in plasma and kidney of patients with lupus nephritis
por: Yang, Yi, et al.
Publicado: (2020) -
Quantitative proteomic analysis by iTRAQ(® )for the identification of candidate biomarkers in ovarian cancer serum
por: Boylan, Kristin LM, et al.
Publicado: (2010) -
A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics
por: Boylan, Kristin LM, et al.
Publicado: (2014)